Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentation.
Alexis A, Del Rosso JQ, Forman S, Martorell A, Browning J, Laquer V, Desai SR, York JP, Chavda R, Dhawan S, Moore AY, Stein-Gold L. Alexis A, et al. Among authors: chavda r. Int J Dermatol. 2024 Jun;63(6):806-815. doi: 10.1111/ijd.17189. Epub 2024 Apr 29. Int J Dermatol. 2024. PMID: 38685118 Clinical Trial.
Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.
Schleicher S, Moore A, Rafal E, Gagne-Henley A, Johnson SM, Dhawan S, Chavda R, York JP, Sforzolini B, Holcomb K, Ablon G, Del Rosso J, Dreno B. Schleicher S, et al. Among authors: chavda r. Dermatol Ther (Heidelb). 2023 Dec;13(12):3085-3096. doi: 10.1007/s13555-023-01042-7. Epub 2023 Oct 15. Dermatol Ther (Heidelb). 2023. PMID: 37838987 Free PMC article.
Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.
Schleicher S, Moore A, Rafal E, Gagne-Henley A, Johnson SM, Dhawan S, Chavda R, York JP, Sforzolini B, Holcomb K, Ablon G, Del Rosso J, Dreno B. Schleicher S, et al. Among authors: chavda r. Dermatol Ther (Heidelb). 2024 Feb;14(2):559-561. doi: 10.1007/s13555-023-01090-z. Dermatol Ther (Heidelb). 2024. PMID: 38216821 Free PMC article. No abstract available.
Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
Dréno B, Bissonnette R, Gagné-Henley A, Barankin B, Lynde C, Chavda R, Kerrouche N, Tan J. Dréno B, et al. Among authors: chavda r. Am J Clin Dermatol. 2019 Oct;20(5):725-732. doi: 10.1007/s40257-019-00454-6. Am J Clin Dermatol. 2019. PMID: 31209851 Clinical Trial.
Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris.
Dréno B, Layton AM, Troielli P, Rocha M, Chavda R. Dréno B, et al. Among authors: chavda r. Eur J Dermatol. 2022 Jul 1;32(4):445-450. doi: 10.1684/ejd.2022.4275. Eur J Dermatol. 2022. PMID: 36301750 Review. English.
Management of Acne Vulgaris With Trifarotene.
Tan J, Chavda R, Baldwin H, Dreno B. Tan J, et al. Among authors: chavda r. J Cutan Med Surg. 2023 Jul-Aug;27(4):368-374. doi: 10.1177/12034754231163542. Epub 2023 Mar 16. J Cutan Med Surg. 2023. PMID: 36927117 Free PMC article. Review.
Clinical characteristics and disease burden in prurigo nodularis.
Aggarwal P, Choi J, Sutaria N, Roh YS, Wongvibulsin S, Williams KA, Huang AH, Boozalis E, Le T, Chavda R, Gabriel S, Kwatra SG. Aggarwal P, et al. Among authors: chavda r. Clin Exp Dermatol. 2021 Oct;46(7):1277-1284. doi: 10.1111/ced.14722. Epub 2021 Jun 22. Clin Exp Dermatol. 2021. PMID: 33969517
74 results